Financials in CAD. Standardized financial statements.
A compact view of how Kane Biotech Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $427,869 | $2.08M | $148,980 | $156,733 | $1.61M | $1.34M | $1.69M | $506,273 | $1.04M | $244,756 |
| Revenue Growth? | -79.4% | +1296.8% | -4.9% | -90.3% | +19.8% | -20.8% | +234.5% | -51.1% | +323.0% | 0.0% |
| Cost of Revenue? | $591,247 | $1.21M | $39,510 | $1.26M | $1.04M | $814,715 | $1.08M | $390,802 | $122,403 | $124,225 |
| Gross Profit? | -$163,378 | $872,096 | $109,470 | $1.41M | $568,441 | $526,859 | $609,912 | $115,471 | $912,899 | $120,531 |
| Gross Margin? | -38.2% | +41.9% | +73.5% | +901.7% | +35.4% | +39.3% | +36.0% | +22.8% | +88.2% | +49.2% |
| Operating Expenses? | $2.95M | $4.80M | $3.47M | $4.78M | $5.45M | $4.75M | $4.20M | $3.29M | $3.61M | $2.69M |
| Operating Income? | -$3.11M | -$4.49M | -$3.36M | -$3.46M | -$4.88M | -$4.22M | -$3.59M | -$3.18M | -$2.69M | -$2.43M |
| EBITDA? | -$2.95M | -$3.71M | -$3.23M | -$2.95M | -$4.25M | -$3.65M | -$764,081 | -$3.10M | -$3.24M | -$2.38M |
| Income Before Tax | -$2.83M | -$4.47M | -$4.56M | -$4.02M | -$4.85M | -$3.85M | -$960,178 | -$3.26M | -$2.79M | -$2.55M |
| Income Tax Expense | -$108,005 | -$1.31M | $0 | $0 | $0 | $0 | $0 | $0 | $90,758 | $0 |
| Net Income? | -$2.72M | -$3.02M | -$5.03M | -$3.89M | -$4.60M | -$3.72M | -$960,178 | -$3.26M | -$2.79M | -$2.55M |
| EPS? | $-0.02 | $-0.02 | $-0.04 | $-0.03 | $-0.04 | $-0.03 | $-0.01 | $-0.04 | $-0.05 | $-0.07 |
| Diluted EPS? | $-0.02 | $-0.02 | $-0.04 | $-0.03 | $-0.04 | $-0.03 | $-0.01 | $-0.04 | $-0.05 | $-0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality